Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Volume: 447,000 (US) 375,999 (on all Canadian exchanges)

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Aug 31, 2023 4:32pm

337 Views

Post# 35614584

Volume: 447,000 (US) 375,999 (on all Canadian exchanges)

I think we can expect good things over the coming weeks.

Like a catch-up in our valuation if such US volume continues in order

That would be more than due, given we're halfway (50%) into a pivotal Ph. 2, for a only 2-doses treatment that delivers high efficacy and no toxicity, with constructive pre-Breakthrough Therapy feedback with the FDA.

We have lots of catch-up to do. Lots of upside. Reaching 300M$US could be a good positioning.

Volume: 447,000 (US) 375,999 (on all Canadian exchanges)

https://www.stockwatch.com/Quote/DetailM.aspx?U:TLTFF

https://www.stockwatch.com/Quote/DetailM.aspx?C:TLT

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch